JR Mascola

411 citations
12 papers · 147 indexed · h-index 3
Topics
HIV Research and Treatment (9 papers)Monoclonal and Polyclonal Antibodies Research (8 papers)Glycosylation and Glycoproteins Research (4 papers)

In The Last Decade

JR Mascola

11 papers receiving 141 citations

Peers

JR Mascola
Comparison fields: 5 of 30
  • Virology 121
  • Infectious Diseases 91
  • Molecular Biology 30
  • Epidemiology 28
  • Immunology 20
Replace Chonticha Kittinunvorakoon with:
Chonticha Kittinunvorakoon Thailand
Lynn Tyers South Africa
Deelan Doolabh South Africa
Kelly A. Curtis United States
Dani Vézina Canada
David Matten South Africa
Fernanda Heloise Côrtes Brazil
Mangaiarkarasi Asokan United States
Nelson Michael United States
Ellena Brooks Australia
JR Mascola relative to Chonticha Kittinunvorakoon Thailand Chonticha Kittinunvorakoon's profile →
Citations per field
00.5×
Chonticha Kittinunvorakoon · 1×
Citations per year

Countries citing papers authored by JR Mascola

Since Specialization
Citations

This map shows the geographic impact of JR Mascola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JR Mascola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JR Mascola more than expected).

Fields of papers citing papers by JR Mascola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JR Mascola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JR Mascola. The network helps show where JR Mascola may publish in the future.

Co-authorship network of co-authors of JR Mascola

This figure shows the co-authorship network connecting the top 25 collaborators of JR Mascola. A scholar is included among the top collaborators of JR Mascola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JR Mascola. JR Mascola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4 1
5 17
6 1
7 1
8 2
9 0
10 2
11 1
12 118

About JR Mascola

JR Mascola is a scholar working on Virology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 12 papers that have together received 147 indexed citations. Recurring topics across this work include HIV Research and Treatment (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Virology (121 citations), Infectious Diseases (91 citations) and Immunology (20 citations). JR Mascola has collaborated with scholars based in United States, Sweden and France. Frequent co-authors include Donald S. Burke, Andrew W. Artenstein, Merlin L. Robb, Thomas C. VanCott, D L Birx, Jariyanart Gaywee, Patricia Hegerich, F. E. McCutchan, Sorachai Nitayaphan and Jean K. Carr. Their work appears in journals such as The Journal of Infectious Diseases, Annals of Oncology and Retrovirology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026